Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | -1.13% | +1.16% | -6.60% |
Apr. 05 | RTW Biotech invests in cell and gene therapy company Obsidian | AN |
Apr. 02 | EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises | AN |
Financials (USD)
Sales 2021 | 0.66 | Sales 2022 | 2.17 | Capitalization | 257M |
---|---|---|---|---|---|
Net income 2021 | -64M | Net income 2022 | -39M | EV / Sales 2021 | 564,951,510 x |
Net cash position 2021 | 6.48M | Net cash position 2022 | 6.97M | EV / Sales 2022 | 115,364,471 x |
P/E ratio 2021 |
-5.88
x | P/E ratio 2022 |
-6.52
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.76% |
Latest transcript on RTW Biotech Opportunities Ltd
1 day | -1.13% | ||
1 week | +1.16% | ||
Current month | -0.76% | ||
1 month | -0.76% | ||
3 months | -5.24% | ||
6 months | +14.41% | ||
Current year | -6.60% |
Members of the board | Title | Age | Since |
---|---|---|---|
William Simpson
CHM | Chairman | 68 | - |
Paul Le Page
BRD | Director/Board Member | - | 19-10-29 |
William Scott
BRD | Director/Board Member | 64 | 19-10-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.31 | -1.13% | 237,817 |
24-04-25 | 1.325 | +1.15% | 726,443 |
24-04-24 | 1.31 | -1.13% | 414,876 |
24-04-23 | 1.325 | +1.53% | 658,467 |
24-04-22 | 1.305 | +0.77% | 370,157 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-6.60% | 504M | |
+3.74% | 12.61B | |
+5.50% | 9.01B | |
-3.20% | 5.41B | |
+2.44% | 5.25B | |
+5.63% | 5.19B | |
+14.36% | 4.48B | |
+16.67% | 4.44B | |
+1.53% | 4B | |
+1.56% | 3.75B |
- Stock Market
- Equities
- RTWG Stock